Orchard Software Announces New Electronic Support for Antimicrobial Stewardship
Orchard Software Announces New Electronic Support for Antimicrobial Stewardship
CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN), which supports regulatory requirements and antimicrobial stewardship endeavors.
印第安纳州卡梅尔，2024年4月4日 /PRNewswire/ — 今天，Orchard Software宣布向国家医疗安全网络（NHSN）提供抗微生物药物使用和耐药性（AUR）报告，该报告支持监管要求和抗微生物药物管理工作。
AUR reporting and data analysis promotes antimicrobial stewardship and impedes the transmission of resistant pathogens. In 2024, the NHSN began requiring hospitals to report AUR data as part of the Public Health and Clinical Data Exchange objective of the Promoting Interoperability Program. Orchard's solutions support this integration and provide a mechanism to automate the submission of designated antibiotic interpretations and susceptibility results to NHSN via HL7 interface.
AUR 报告和数据分析促进抗微生物药物管理，阻碍耐药性病原体的传播。2024年，作为促进互操作性计划公共卫生和临床数据交换目标的一部分，NHSN开始要求医院报告AUR数据。Orchard的解决方案支持这种整合，并提供了一种通过HL7接口自动向NHSN提交指定的抗生素解释和敏感性结果的机制。
"At Orchard, we are continually looking for ways to support our customers and the valuable work they do. Adding AUR reporting is one more way that we can provide superior support to our customers," said Billie Whitehurst, CEO of Orchard Software. "We understand the importance of antimicrobial stewardship and that improving the use of antimicrobials to prevent antibiotic resistance is one of the CDC's core objectives. We are pleased to contribute to tracking of antimicrobial use as a tool for improvement within the laboratory and public health industries."
“在 Orchard，我们一直在寻找方法来支持我们的客户和他们所做的宝贵工作。添加AUR报告是我们为客户提供卓越支持的另一种方式。” Orchard Software首席执行官比利·怀特赫斯特说。“我们了解抗微生物药物管理的重要性，改善抗微生物药物的使用以预防抗生素耐药性是疾病预防控制中心的核心目标之一。我们很高兴为跟踪抗微生物药物的使用情况做出贡献，以此作为改善实验室和公共卫生行业的工具。”
AUR is used to track antimicrobial resistant infections and evaluate antibiotic use trends over time. Providing antimicrobial usage reports to providers can improve appropriate antimicrobial use. Orchard's solutions support this endeavor and are easily configurable to include antibiotic interpretations that enable required reporting to NHSN.
AUR 用于跟踪抗微生物药物耐药性感染和评估一段时间内的抗生素使用趋势。向提供者提供抗微生物药物使用报告可以改善抗微生物药物的适当使用。Orchard 的解决方案支持这项工作，并且易于配置以包括抗生素解释，从而能够按要求向 NHSN 报告。
About Orchard Software Corporation
Orchard Software Corporation is a leader in the laboratory information system industry and offers a variety of solutions. Orchard serves more than 2,000 laboratories across the country, helping them improve efficiency, reduce errors, and enhance integration. Orchard's cloud-based solutions are installed in physician groups and clinics, hospitals, independent reference labs, student health centers, veterinary labs, public health organizations, universities, and retail facilities. For more information regarding Orchard Software Corporation, visit .
Orchard 软件公司简介
Orchard Software Corporation是实验室信息系统行业的领导者，提供各种解决方案。Orchard 为全国各地的 2,000 多个实验室提供服务，帮助他们提高效率、减少错误和加强整合。Orchard 基于云的解决方案安装在医生团体和诊所、医院、独立参考实验室、学生健康中心、兽医实验室、公共卫生组织、大学和零售设施中。有关 Orchard 软件公司的更多信息，请访问。
Media Contact:
Steve Hurwitz, Vice President of Marketing
(800) 856-1948 | [email protected]
媒体联系人：
Steve Hurwitz，市场营销副总裁
(800) 856-1948 | [电子邮件保护]
SOURCE Orchard Software Corporation
来源 Orchard 软件公司